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Abstract 
Affinity chromatography is one of the most selective and versatile forms 
of liquid chromatography for the separation or analysis of chemicals in 
complex mixtures. This method makes use of a biologically related agent 
as the stationary phase, which provides an affinity column with the abil‑
ity to bind selectively and reversibly to a given target in a sample. This 
review examines the early work in this method and various developments 
that have lead to the current status of this technique. The general princi‑
ples of affinity chromatography are briefly described as part of this dis‑
cussion. Past and recent efforts in the generation of new binding agents, 
supports, and immobilization methods for this method are considered. 
Various applications of affinity chromatography are also summarized, as 
well as the influence this field has played in the creation of other affin‑
ity-based separation or analysis methods.
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1 Introduction 
Most samples in nature consist of a complex mixture of many sub‑
stances. This fact has led to the development of chemical separation 
methods such as liquid chromatography to purify, analyze, or exam‑
ine the components of such samples. The variety of chemical inter‑
actions and formats that can be employed in these separations, as 
based on the types of stationary phases and mobile phases that are 
used, has resulted in the creation of many types of liquid chroma‑
tography [1]. For instance, reversed phase chromatography or nor‑
mal phase chromatography can be utilized to separate chemicals 
based on their polarity, ion exchange chromatography makes use 
of ionic interactions, and size exclusion chromatography separates 
chemicals based on their size. Such methods can also be classified 
as low-performance or high-performance techniques based on the 
support materials that are used and the types of column efficiencies 
that are obtained. The large variety of such methods has resulted in 
liquid chromatographic methods being employed for the separation 
or analysis of many types of chemicals in liquid-phase samples. As a 
result, it is not surprising that liquid chromatography is a common 
liquid-phase separation method that is found in both industrial set‑
tings and research laboratories [1]. 
Perhaps the most selective, versatile, and complex form of liq‑
uid chromatography is the method of affinity chromatography. This 
method is a type of liquid chromatography that uses a biologically re‑
lated agent as the stationary phase [2–7]. As this definition suggests, 
affinity chromatography is based on the reversible and specific bind‑
ing that is often found in biological interactions. Examples of these in‑
teractions include the binding of an antibody with its target (or anti‑
gen), the binding of a hormone with its receptor, and the interaction 
of an enzyme with its substrate. This type of selective binding is used 
in affinity chromatography by placing within the column one of the 
interacting agents and immobilizing this agent to a support for use as 
a stationary phase. This immobilized binding agent is called the “af‑
finity ligand,” and it forms the basis by which the complementary tar‑
get can be isolated or purified by the affinity column. 
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2 General Principles of Affinity Chromatography 
Figure 1 shows a few ways in which an immobilized affinity li‑
gand can be used in a chromatographic separation. In each of these 
approaches, a sample that contains the desired target is applied to 
the column in the presence of a mobile phase that has the correct 
composition and pH to promote binding of the target to the affin‑
ity ligand. This mobile phase is often referred to as the “application 
buffer” and represents the weak mobile phase for this column (i.e., 
the liquid phase in which the column will have its highest retention 
of the target). When the sample is applied to the affinity column in 
the presence of this mobile phase, the target will be retained but, 
due to the selective nature of the immobilized binding agent, other 
Fig. 1 Examples of typical (a) application and (b) elution sequences for affinity chro‑
matography. The isocratic elution method in (b) uses the same solution for both sam‑
ple application and elution from the column. The nonspecific elution method in (b) 
uses a separate solution for elution that has a different pH, ionic strength, polarity 
or temperature from the solution used for sample application. The biospecific elu‑
tion methods in (b) make use of an elution buffer that contains an agent that will 
compete with the affinity ligand for binding to the target (normal role) or that com‑
petes with the target for binding to the affinity ligand (reversed role). 
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components in the sample will tend to pass through the column in 
the nonretained fraction or as a weakly retained peak. The retained 
target is then eluted from the column and measured, collected for 
further use, or passed onto a second method for further separation 
or analysis. 
There are several ways in which the retained target can be removed 
from the affinity column, as shown in Fig. 1. If this target has only 
moderately strong binding to the column (e.g., an association equi‑
librium constant of 105–106 M −1 or less), it may be possible to use iso‑
cratic elution. In this approach, known as weak affinity chromatogra‑
phy, the application buffer is utilized both to apply the sample to the 
affinity column and to later elute the retained target. A more common 
method is to use a step change or gradient to elute the retained target 
after the nonretained sample components have left the column. This 
approach, sometimes known as the “on/off” elution method, uses a 
second mobile phase to cause the target to leave the column due to 
dissociation or mass action, as is demonstrated in Fig. 1 through the 
use of nonspecific elution or biospecific elution. The second mobile 
phase that is used in this case is called the “elution buffer” and rep‑
resents the strong mobile phase for the column (i.e., a mobile phase 
that leads to low target retention). After this elution buffer has re‑
moved the target from the column, the original buffer is reapplied 
and the column is allowed to regenerate prior to the next sample be‑
ing passed through the column.  
As will be shown in this review, there are many types of binding 
agents, supports, and separation formats that can be employed in af‑
finity chromatography. These features, plus the high selectivity of 
many affinity ligands, have made this method popular in the larges‑
cale purification of enzymes and biopharmaceuticals [2–4]. Other ap‑
plications have included the small-scale isolation of recombinant pro‑
teins, the analysis of specific chemicals in biological or pharmaceutical 
samples, and the study of biological interactions [2–6]. The remain‑
der of this review will examine the history of affinity chromatogra‑
phy and consider events and trends that have led to the development 
and current applications of this technique. 
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3 The Origins of Affinity Chromatography 
The first known report of a separation that used affinity chroma‑
tography occurred in the early 1900s. This was a period of time in 
which the method of liquid chromatography itself was still in its in‑
fancy. Some work had already been carried out in the late 1800s for 
liquid-phase separations based on the adsorption of chemicals to pla‑
nar supports [1]. In addition, the utilization of packed columns and 
the adsorption of targets to a solid support had been explored in 1903–
1907 by Michael Tswett for the separation of plant pigments [8]. A few 
years later, in 1910, Emil Starkenstein studied binding by the enzyme 
α-amylase to a column containing insoluble starch [9]. The method 
used by Starkenstein, which was based on the natural interactions that 
occur between α-amylase and starch, this enzyme’s substrate, was not 
only the first known example of affinity chromatography but was also 
one of earliest examples of a separation in which liquid chromatogra‑
phy was used with an enzyme or protein. 
Methods similar to the one used by Starkenstein were soon de‑
scribed by others who were working with the enzyme amylase. Ex‑
amples included several papers which appeared over the next few de‑
cades, such as work by Ambard in 1921 [10], Holmbergh in 1933 [11], 
Tokuoka in 1937 [12], and Hockenhull and Herbert in 1945 [13]. In 
one of these reports, a 300-fold purification of amylase was even re‑
ported [14]. This general approach was also adopted for the purifica‑
tion or isolation of other enzymes that had substrates which could be 
obtained in a solid or powdered form and used as support materials. 
For instance, in 1934 Northrup used edestin, a crystalline protein, to 
purify the protease pepsin [14]. Lineweaver et al. employed polyga‑
lacturonase in 1949 as both a support and affinity ligand for binding 
to alginic acid [15]. In addition, Grant and Robbins described work in 
1957 in which they used powdered elastin to isolate the enzyme por‑
cine elastase [16]. 
As these efforts were made on the use of substrates and solid sup‑
ports to purify enzymes, parallel reports appeared on the purifica‑
tion of antibodies by their selective binding to biological ligands. This 
type of work with antibodies was based on a report in 1920 by Land‑
steiner in which it was found that antibodies could bind “antigens” 
(i.e., chemicals that had a specific and complementary structure to the 
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antibodies) [17]. In addition, it was found that large antigens could 
bind with polyclonal antibodies to form complexes that precipitated 
from an aqueous solution. The result was the creation of a method 
known as immunoprecipitation, which appeared in the 1930s as a tool 
for antibody characterization and purification [18–20]. As an exam‑
ple, immunoprecipitation was utilized in 1934 by Kirk and Sumner to 
purify antibodies for urease and to demonstrate that these antibodies 
were proteins [18]. Although this particular approach was not yet at 
the point where it would now be called “chromatography,” such work 
did demonstrate that the use of selective binding for purification and 
analysis was not limited to enzyme–substrate interactions but could 
be extended to antibody–antigen binding, and perhaps other types of 
biological systems. 
4 Early Developments in Affinity Supports and Immobilization 
Methods 
The earliest affinity-based separations, as described in the previ‑
ous section, all made use of naturally occurring materials as both the 
support and binding agent. Examples included the use of supports 
such as insoluble starch for the isolation of amylase [9–13], polyga‑
lacturonase for alginic acid [15], crystalline edestin for pepsin [14], 
and powdered elastin for elastase [16]. The reports that utilized im‑
munoprecipitation employed a similar scheme based on naturally oc‑
curring solid supports, but in these studies the support was the pre‑
cipitate that was created as the result of the specific binding between 
an antigen and its antibodies [18–20]. 
The next step in the development of affinity-based separations was 
the creation of supports which could be used for binding agents and 
targets for which naturally occurring ligand/support combinations 
were not available. This work first involved binding agents that were 
attached to supports by means of noncovalent adsorption. One exam‑
ple of this occurred in 1935 when D’Alessandro and Sofia coated an‑
tigens onto charcoal or kaolin and used these modified supports to 
isolate antibodies that were related to tuberculosis and syphilis [21]. 
A similar antibody-purification method that used antigens on kaolin 
was described by Meyer and Pic in 1936 [22]. Although these supports 
Hage & Matsuda in Affinity Chromatography: Methods & Protocols  (2015)      7
were relatively easy to prepare, one issue in using a support prepared 
by ligand adsorption was that the binding properties of such a mate‑
rial may not have good long-term stability due to gradual loss of the 
binding agent [2]. 
Approaches for the creation of supports that contained covalently 
linked binding agents soon began to appear. This approach was used 
in 1936 by Landsteiner and van der Scheer, who adapted a diazo cou‑
pling method that had already been used to prepare hapten conjugates 
[23]. In their modified approach, they used this method to couple var‑
ious haptens to chicken erythrocyte stroma. This modified material 
was then used to isolate antibodies that could bind to the immobi‑
lized haptens. Another important advance took place in 1951 in work 
by Campbell, Luescher and Lerman [24]. In their research, they acti‑
vated cellulose to give p-aminobenzylcellulose, which was then used 
to immobilize bovine serum albumin (BSA). The resulting material 
was employed in the isolation of anti- BSA antibodies that were pres‑
ent in pooled serum from rabbits that had previously been injected 
and immunized with BSA [24]. 
Other reports that used binding agents covalently linked to solid 
supports soon began to appear. For instance, the same method as 
used by Campbell et al. was employed by Lerman to immobilized hap‑
tens in 1953 for “antibody chromatography” [25]. Lerman also used 
this approach to prepare a support with an immobilized ligand for the 
purification of mushroom tyrosinase [26]. Other reports using cova‑
lently linked antigens for antibody purification appeared in 1955 by 
Manecke and Gillert, who used polyaminostyrene as the support [27], 
and in 1958 by Sutherland and Campbell, who utilized glass beads 
for antigen immobilization [28]. From 1957 through 1966, several re‑
views and additional papers appeared on methods for the covalent 
immobilization of antigens, enzymes or antibodies to solid materi‑
als [29–35]. Much of this work focused on supports containing im‑
mobilized antibodies, antigens or haptens, but some reports related 
to enzyme purification were published as well. Of particular interest 
in this latter group were two papers by Arsenis and McCormick in 
1964 and 1966, in which various flavin-cellulose supports were used 
for the purification of flavokinase [36] and flavin mononucleotidede‑
pendent enzymes [37]. 
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There were a series of critical developments that next occurred 
around the mid- to late-1960s. One of these developments was the 
creation of beaded agarose by Hjerten in 1964 [38]. This material was 
important because it was more efficient and more readily adaptable 
than cellulose for use with proteins and biopolymers in liquid chro‑
matography. A second development, which occurred in 1967, was the 
description of the cyanogen bromide immobilization method by Axen, 
Porath, and Ernback (see Fig. 2) [39]. The value of this immobiliza‑
tion method was that it allowed for a general and relatively conve‑
nient means for covalently coupling peptides and proteins to polysac‑
charide-based materials. In 1968, Cuatrecasas, Wilchek, and Anfinsen 
[40] combined these two approaches when they used the cyanogen 
bromide method to immobilize nuclease inhibitors to beaded aga‑
rose. These supports were then placed into columns and used to pu‑
rify several enzymes, including carboxypeptidase A, α-chymotrypsin, 
and staphylococcal nuclease [40]. This general method was adapted 
by many others [2–6] and became known by the name “affinity chro‑
matography” [2–7, 40]. 
Fig. 2 The cyanogen bromide (CNBr) immobilization method. This figure shows two 
possible routes by which ligands can be coupled to a support.  
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5 The Modern Area of Affinity Chromatography 
Immediately after 1968, there was rapid growth in the field of af‑
finity chromatography and in the applications of this method. This 
growth is indicated in Fig. 3 by the way in which the number of publi‑
cations including the term “affinity chromatography” grew from only 
a few in the late 1960s to around 1,000 papers per year or more by 
the early 1980s. Over the last decade, this number has risen to around 
1,500 papers per year, giving a total of over 43,000 publications on 
this topic that have appeared between 1968 and 2013. This period of 
time has also seen the creation of a large range of methods and appli‑
cations that make use of affinity chromatography. The remainder of 
this review will briefly consider many of these developments. 
5.1 Advances in Affinity Ligands 
One way in which affinity chromatographic methods can be catego‑
rized is in terms of the type of binding agent that is present in the col‑
umn. As was noted earlier, the first binding agents used in this method 
Fig. 3 Number of publications including the term “affinity chromatography” and 
that appeared between 1968 and 2013. These data were obtained through a search 
that was conducted in April 2014 on the Web of Science. 
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were those that were based on the interactions of enzymes with their 
substrates, inhibitors or cofactors and on the interactions of antibod‑
ies with their antigens. These two groups of interactions are still used 
in many of the modern applications of affinity chromatography. Ex‑
amples include the use of affinity chromatography for enzyme puri‑
fication, antibody isolation, and the selective purification or removal 
of antigen- or antibody-related targets from samples [2–6]. 
The use of a biological molecule as the binding agent in affinity 
chromatography, such as an enzyme or antibody, is a method known as 
bioaffinity chromatography or biospecific adsorption [2–6, 41]. There 
are many natural binding agents that have been employed in affinity 
columns, which has resulted in the development of several subcatego‑
ries for bioaffinity chromatography. The most common subcategory is 
one which uses a ligand that is an antibody or antibody-related agent 
(e.g., an antigen or an antibody fragment), giving a technique known 
as immunoaffinity chromatography (IAC) [42–46]. 
Another subset of bioaffinity chromatography is lectin affinity chro‑
matography, which uses binding agents that consist of lectins (i.e., 
nonimmune system proteins that can bind to particular carbohydrate 
residues) [41, 47–49]. Examples of lectins that are often used in affin‑
ity columns are concanavalin A (Con A), which can bind to α-D-glucose 
or α-D-mannose residues, and wheat germ agglutinin (WGA), which 
interacts with D-N-acetylglucosamine residues [3–6, 41, 49]. Some 
other natural ligands that have been employed in bioaffinity chroma‑
tography are immunoglobulinbinding proteins like protein A or pro‑
tein G, which can be used for antibody purification or as secondary 
binding agents to adsorb antibodies to a support [6, 41, 49–52]. In ad‑
dition, nucleic acids and polynucleotides can be utilized in bioaffinity 
chromatography to purify enzymes and proteins that bind to DNA or 
RNA, as well as to retain nucleic acids that have a complementary se‑
quence to the immobilized binding agent [53–55]. 
Various nonbiological binding agents have also been employed in 
affinity chromatography. Some illustrations of this approach appeared 
during the early creation of synthetic agents and modified supports 
for the purification of enzymes and antibodies, as described in the 
previous section. Other examples that began to appear in the 1970s 
included the techniques of immobilized metal-ion affinity chroma‑
tography (IMAC) [56], dye-ligand affinity chromatography [57], and 
boronate affinity chromatography [58], as illustrated in Fig. 4.
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In IMAC, the affinity ligand is a metal ion that is bound to a chelating 
agent on the support (e.g., Ni2+ on a support that contains iminodiacetic 
acid, or IDA) [56, 59–62]. IMAC can retain peptides, proteins and other 
targets that have electron donor groups, making this method popular in 
molecular biology for the purification of histidine-tagged proteins and 
in proteomics for the isolation of phosphorylated proteins [60]. Dye-li‑
gand affinity chromatography uses a ligand that is a synthetic dye, such 
as Cibacron Blue 3GA [3, 57]. The good stability, low cost, and ability to 
custom design these ligands for a given target have made dye-ligand af‑
finity chromatography popular for the large-scale purification of pro‑
teins and enzymes [63, 64]. Boronate affinity chromatography is based 
on the use of boronic acid or a related derivative as a ligand. This type 
of ligand can retain targets that contain cis-diol groups, such as cate‑
cholamines and many compounds with sugar residues (e.g., polysac‑
charides, glycoproteins, and ribonucleic acids) [65–67]. 
The last few decades have seen increasing interest in the genera‑
tion of new types of affinity ligands through a variety of techniques. 
One example is a technique known as biomimetic affinity chroma‑
tography [63]. As the term “biomimetic” suggests, this method seeks 
to generate or select a ligand that can mimic the binding of a desired 
target to some natural compound. This approach includes the use of 
Fig. 4 Examples of nonbiological ligands that are used in (a) boronate affinity chro‑
matography, (b) immobilized metal-ion affinity chromatography (IMAC), and (c) 
dye-ligand affinity chromatography.  
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synthetic dyes as ligands, making dye-ligand affinity chromatography 
a subset of these biomimetic techniques [63]. There are many ways in 
which artificial ligands can be produced. Some examples of these ap‑
proaches are the use of phage display libraries, aptamer libraries, and 
ribosome display libraries. The creation of affinity ligands through the 
use of peptide libraries, combinatorial chemistry, and computer mod‑
eling has also been an area of active research [63, 68, 69]. 
An alternative approach that has been explored to create artificial 
ligands is molecular imprinting [70–73]. In this technique, the affinity 
ligand is a binding pocket for the target and is formed during creation 
of the support. This material can be prepared by combining a known 
portion of the desired target with a polymerization mixture that con‑
tains a cross-linking agent, an initiating agent for polymerization, and 
one or more monomers with functional groups that can interact with 
the target. As this mixture polymerizes and forms the support, pockets 
are produced about the target that have a shape and set of functional 
groups that complement the target’s structure. After this molecularly 
imprinted polymer (MIP) has been generated, the target is removed and 
the pockets in this material are utilized as affinity ligands to retain and 
bind the same target in samples that are applied to this support [70–73]. 
5.2 Advances in Affinity Supports and Immobilization Methods 
Another way affinity chromatography has continued to develop is in 
the types of supports and immobilization methods that have been em‑
ployed in this technique. Carbohydrate-based materials such as aga‑
rose remain the most common media for preparative applications of 
affinity chromatography. Features of these supports that make them 
useful for large-scale purifications and sample pretreatment include 
their low nonspecific binding, low cost, and ability to be used over a 
broad pH range for elution or with solutions that are often employed 
for column sterilization. These supports can also be employed with a 
variety of immobilization methods [2–6, 49, 74]. The main downside 
for many of these materials is their relatively low efficiency and their 
ability to be used at only modest back pressures. A method with such 
properties is sometimes known as low-performance (or column) af‑
finity chromatography [2, 75, 76]. 
Soon after beaded agarose was used in affinity chromatography, 
alternative supports were considered for this method. Some of these 
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materials were based on silica or glass beads, which provided better ef‑
ficiencies and mechanical stability than carbohydrate-based supports. 
The use of such materials gave a method known as high performance 
affinity chromatography or high-performance liquid affinity chromatog‑
raphy [6, 76–79]; however, these supports did require some prior mod‑
ification to minimize their nonspecific binding for biological agents [6]. 
A range of synthetic organic-based supports were also created for affin‑
ity chromatography. These latter supports included azalactone beads, 
hydroxylated polystyrene, polyacrylamide derivatives, polyethersulfone, 
and polymethacrylate derivatives, as well as hybrid materials like aga‑
rose–acrylamide and dextran–acrylamide copolymers. Like agarose, 
these alternative supports have now been used with many affinity li‑
gands and immobilization methods [3–6, 32, 78, 79]. 
There are various forms in which the support can be used in af‑
finity chromatography. The most common form is that of a particu‑
late support that is packed within a column. This type of support may 
consist of agarose or cellulose beads, silica particles, glass beads, or 
particles of an organic polymer like azalactone or polyacrylamide. 
Monolithic supports have also been used with affinity ligands over 
the last decade, giving a method known as “affinity monolith chro‑
matography”; in this approach, a porous bed made of a continuous 
material is used in the affinity column [75]. Monolith columns have 
been prepared by using media such as agarose, silica, polymethac‑
rylate or other organic polymers, and cryogels (e.g., see Fig. 5) [75, 
76, 79, 80]. Other support formats that have been utilized in affinity 
Fig. 5 Typical procedure used to prepare an organic monolith based on a copolymer 
of glycidyl methacrylate (GMA) and ethylene glycol dimethacrylate (EDMA) for use 
in affinity monolith chromatography.
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chromatography have included fibers, membranes, nonporous par‑
ticulate supports, flow-through particles (e.g., perfusion media), and 
expanded bed particles [79]. 
The approach that is most frequently used in modern affinity chro‑
matography to place ligands onto these supports is covalent immobi‑
lization. There are many methods that can be used for this purpose 
[3–6, 49, 74, 78]. For example, this might make use of amine groups, 
carboxylic acids, or sulfhydryl residues in the structure of a ligand 
such as a protein or peptide. Alternative schemes can also sometimes 
be employed, such as the use of aldehyde groups that are generated 
through the oxidation of carbohydrate residues [49, 74, 81]. In addi‑
tion, many of these procedures can now be carried out by using kits 
or preactivated supports that are commercially available [49, 74]. 
Physical adsorption, which was used in some early forms of affin‑
ity chromatography, is still used on occasion for ligand immobiliza‑
tion. This method is usually easy to carry out but can result in a li‑
gand that may wash from the column over time or may use a support 
material that will have nonspecific binding to some sample compo‑
nents [74]. A common variation of this method is biospecific adsorp‑
tion, which uses a secondary ligand that is coupled within the column 
to selectively adsorb the final desired affinity ligand. A few examples 
of this approach are the use of immobilized streptavidin or avidin to 
bind to affinity ligands that have been tagged with biotin, and the use 
of immobilized protein A or protein G to adsorption antibodies to af‑
finity supports [41, 43, 49, 74].  
Another method for ligand immobilization that has been of inter‑
est is entrapment or encapsulation [74]. One way to accomplish this 
is to combine the affinity ligand with the chemicals that are used to 
make an affinity support, such as occurs when a sol–gel is prepared 
in the presence of a protein or other type of ligand [74]. It is also pos‑
sible to place large ligands like liposomes or membrane-based parti‑
cles within the pores of some supports (e.g., agarose) by altering the 
size of the ligand particles through a process such as freeze-drying 
[82, 83]. Another approach that has recently been used for entrap‑
ment is to place soluble proteins and other affinity ligands in porous 
supports by at least partially blocking the support’s pores through the 
use of a large capping agent [84, 85]. 
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5.3 Advances in Applications of Affinity Chromatography and 
Related Methods 
As was true during the initial development of affinity chromatog‑
raphy, one of the key applications for this method is its use in the se‑
lective purification of biochemicals. The variety of ligands and sup‑
ports that are now available have made this technique valuable for 
both small- and large-scale purification methods. A small-scale exam‑
ple is the use of IMAC to isolate and purify histidine-tagged proteins, 
as are often produced in molecular biology [60]. Important examples 
of large-scale purifications include the use of various forms of affin‑
ity chromatography to isolate enzymes, recombinant proteins, and bi‑
opharmaceutical products [63, 64, 86–90].  
The high selectivity of affinity ligands, and the creation of improved 
support materials for these ligands, has also led to the growth of af‑
finity chromatography as an important tool for chemical analysis [2, 
6, 76–80]. This has included the use of this method in fields that have 
ranged from biochemistry and clinical chemistry to pharmaceutical 
analysis and environmental science [88, 91–94]. Some of these appli‑
cations have used affinity chromatography as a means of binding to a 
particular target and then measuring this target directly as it elutes 
from the affinity column [6, 43, 46, 92–96]. In some cases, such as 
chiral separations, an affinity column can be used to retain and re‑
solve multiple targets that bind to the affinity ligand [92, 97–100]. 
Many other examples have used affinity ligands, and especially anti‑
bodies, to extract a given target or group of targets prior to the anal‑
ysis of these compounds by a second method (e.g., reversed phase 
chromatography, gas chromatography, capillary electrophoresis, or 
mass spectrometry) [42–44, 96, 101, 102]. Affinity columns have also 
been employed with various detection schemes for the indirect detec‑
tion of a target, such as occurs in the use of antibodies in chromato‑
graphic-based immunoassays or in schemes that employ post column 
immunodetection to examine specific targets as they elute from more 
traditional types of liquid chromatographic columns [44, 46, 95, 96, 
102, 103]. Both the specificity and strong binding of many biological 
ligands have also made affinity columns attractive in recent years as 
components for the processing or analysis of targets by microscale an‑
alytical devices [96, 101, 104, 105]. 
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Another application for affinity chromatography has been the use 
of this method in the study of biological interactions [106–111]. Zonal 
elution is one approach that was used as early as 1973–1974 for this 
purpose [112, 113] and has been employed with such systems as pro‑
tein–protein, drug–protein, and enzyme– inhibitor interactions [106, 
107, 109]. This method makes use of the injection of a small amount 
of a probe compound or solute onto an affinity column, and is usually 
done in the presence of a competing agent or additive in the mobile 
phase. This method can provide data on the binding strength of the 
ligand to the injected probe/solute or additive and on the types of in‑
teractions that are present between these agents [107, 109]. Frontal 
analysis, or frontal affinity chromatography (FAC), is an alternative 
approach for binding studies that has been used since 1975 [114]. This 
method involves the continuous application of a known concentration 
of a target to an affinity column, with the results being used to find 
the equilibrium constant(s) and number of binding sites for the tar‑
get with the affinity ligand [106, 107, 109]. In the early-to-mid 1990s, 
similar zonal elution and frontal analysis schemes were adapted for 
use in capillary electrophoresis, creating a set of methods now known 
as affinity capillary electrophoresis (ACE) [115–119].  
Work in the mid-1970s through early-1980s also lead to the devel‑
opment of various ways for examining the kinetics of biological inter‑
actions by using affinity chromatography. An early example of such 
an approach was a variation on zonal elution that made use of band-
broadening measurements [106, 120–122]. Other methods that were 
described for kinetic studies included those based on the split-peak ef‑
fect, peak decay analysis, and various peak fitting methods [106, 107, 
109, 123–130]. Similar work was then conducted in the use of immo‑
bilized affinity ligands and flow through biosensors for kinetic stud‑
ies [108, 131]. One result of these efforts was the creation of sensors 
and devices that could determine the degree or rate of a target–ligand 
interaction at a surface by measuring changes in optical properties, 
such as based on surface plasmon resonance (SPR) [131–133]. 
6 Conclusion 
Over the last one hundred years, affinity chromatography has 
grown from a method that could be used to isolate only a few enzymes 
Hage & Matsuda in Affinity Chromatography: Methods & Protocols  (2015)      17
or antibodies to a powerful technique that has a broad range of appli‑
cations in chemical separations and analysis. This growth has been 
made possible by the availability of many binding agents, support ma‑
terials, and immobilization methods that can now be used with this 
technique. These developments, in turn, have made it possible for af‑
finity chromatography to become an important separation method for 
both the large- and small-scale purification of biochemicals. Other ap‑
plications that have appeared for this method have included its use 
in the direct or indirect detection of targets and its combination with 
other methods of chemical analysis. Affinity chromatography has also 
become a valuable tool for the study of biological interactions and has 
led to the creation of related affinity methods, such as the use of flow-
based sensors to examine biological interactions and affinity capillary 
electrophoresis. As a result of the many current applications for this 
method, it is expected that affinity chromatography will continue to 
grow and develop in the future as a vital tool in areas that span from 
the production of biopharmaceuticals to clinical analysis, environmen‑
tal testing, pharmaceutical testing, and biomedical research. 
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